NCYT Novacyt S.A.

44.00GBp+10.00%Mkt Cap: 34.68M $P/E: —

Novacyt S.A., together with its subsidiaries, develops, manufactures, and commercializes a range of molecular assays and instrumentation to deliver workflows and services for human health, animal health, and environmenta…

Key Statistics

Company
Market Cap34.68M USD
Enterprise Value30.56M USD
Revenue (TTM)23.69M USD
Gross Profit13.71M USD
Net Income (TTM)-24.87M USD
Revenue/Share0.30 GBp
Last Price44.00 GBp
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees216
CountryGB
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-5.31
PEG—
EV/EBITDA7.55
EV/Revenue1.29
P/S1.23
P/B1.12
EPS (TTM)-0.31
EPS (Forward)-0.07
52W Range
26.6029% of range86.00
52W High86.00 GBp
52W Low26.60 GBp
Profitability
Gross Margin62.98%
Oper. Margin-44.17%
EBITDA Margin17.09%
Profit Margin-114.25%
ROE-97.91%
ROA-56.74%
Growth
Revenue Growth18.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF-9.79M USD
CapEx (TTM)957.61K USD
FCF Margin29.12%
FCF Yield19.89%
Net Debt1.44M USD
Net Debt/EBITDA0.35
Balance Sheet
Debt/Equity0.45
Current Ratio3.14
Quick Ratio2.19
Book Value/Sh0.33 GBp
Cash/Share0.12 GBp
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 GBp
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)66.00 GBp
Upside (mean)+50.0%
Target Range66.00 GBp – 66.00 GBp
# Analysts1
Ownership
Shares Out.72.50M
Float72.21M
Insiders0.06%
Institutions0.00%
Technical
SMA 5041.83 (+5.2%)
SMA 20037.84 (+16.3%)
Beta—
S&P 52W Chg14.58%
Avg Vol (30d)86.93K
Avg Vol (10d)72.80K
Technical Indicators
RSI (14)55.5
MACD-0.1162
MACD Signal0.1464
MACD Hist.-0.2626
BB Upper45.90 GBp
BB Middle42.19 GBp
BB Lower38.48 GBp
BB Width17.58%
ATR (14)2.876 GBp
Vol Ratio (20d)13.37x